Promoter holding
64.27%
SL
Sainor Laboratories Private Limited - Due diligence report
A 360° intelligence report on Sainor Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Sainor Laboratories Private Limited — 360° Intelligence Report
Generated from MCA filings & public records68/100
Trust Score
Moderate
Sainor Laboratories Private Limited is assessed as Moderate with a Trust Score of 68/100. Sainor Laboratories Private Limited is an active private limited indian non-government company incorporated in 2004, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 07 Aug 2026 from the latest processed filings. Sainor Laboratories Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
66/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 65/100 Moderate
- Working-capital cover adequate.
- Externally credit-rated (BBB).
Charges position: 11 open (217.70 cr) · 9 satisfied (73.43 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 12 | 48.0 cr |
| State Bank Of India | 2 | 48.0 cr |
| Union Bank Of India | 2 | 48.0 cr |
| Sbi Global Factors Limited | 1 | 48.0 cr |
| Andhra Predesh State Finance Corporation Limited | 1 | 48.0 cr |
| Kotak Mahindra Bank Limited | 2 | 48.0 cr |
Compliance Score: 66/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (156 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANJANEYA PATTABHI RAMESWARA RAO CHANDANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KADIRI SHILPA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NAGAUDAYA BHASKARAM UDDAGIRI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANAJALI DEVI SUNDARA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PULLAIAH NAIDU SUNDARA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SRINIVAS NADIMINTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UDDAGIRI TATA RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
4 allotment(s) · 1 transfer(s)
| Group entity | Relationship | % held |
|---|---|---|
| Skills Life Sciences Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: ANJANEYA PATTABHI RAMESWARA RAO CHANDANA (Managing Director) · KADIRI SHILPA (Whole-time director) · NAGAUDAYA BHASKARAM UDDAGIRI (Whole-time director) · ANAJALI DEVI SUNDARA (Whole-time director) · PULLAIAH NAIDU SUNDARA (Whole-time director) · SRINIVAS NADIMINTI (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 60
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 21+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
11 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.37 cr.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence65/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 11 open charge(s) of 217.70 cr already registered.
- Compliance gaps should be priced into terms.
Investor view57/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events26 Aug 2025
Charge created
Others - 20.00 cr
Charge created
Others - 17.03 cr
09 Jun 2025
Charge created
Others - 33.34 cr
08 May 2025
Charge created
Others - 84.40 Lakh
20 Feb 2025
Charge satisfied
Union Bank Of India
19 Oct 2024
Charge satisfied
Others
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Share transfer (FY 2024)
196632.00000000 shares to RAMESWARA RAO CH. A.P.
Latest balance sheet
Filed with ROC
15 Nov 2023
Charge created
Others - 27.70 Lakh
22 Dec 2022
Charge created
Others - 4.50 cr
20 Sep 2022
Charge satisfied
Others
20 Jul 2021
Charge created
Others - 50.00 Lakh
03 Dec 2020
Charge created
Others - 125.46 cr
30 Jul 2020
Charge created
Others - 28.10 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of BBB from Icra.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Sarex Organics Private Limited | U24239MH1998PTC115270 | Mumbai, Maharashtra, India |
| Softgel Healthcare | U24231TN2003PTC051829 | Puduppakkam, Tamil Nadu, India |
| Cmrl | L24299KL1989PLC005452 | Ernakulam, Kerala, India |
| Chemfab Alkalis Limited | L24290TN2009PLC071563 | Chennai, Tamil Nadu, India |
| Boroline | U24231WB1955PTC022265 | Kolkata, West Bengal, India |
| Zydus Ahl | U24236GJ2018PLC102269 | Ahmedabad, Gujarat, India |
| Kesar Enterprises Limited | L24116MH1933PLC001996 | Mumbai, Maharashtra, India |
| Sms Lifesciences | L74930TG2006PLC050223 | Hyderabad, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Sainor Laboratories Private Limited before audits and certifications: compliance score 66/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Sainor Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Sainor Laboratories Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Sainor Laboratories Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Sainor Laboratories Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Sainor Laboratories Private Limited an active company?
Sainor Laboratories Private Limited has MCA status “Active” with a compliance score of 66/100 (Moderate).
Is Sainor Laboratories Private Limited financially healthy?
Sainor Laboratories Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Sainor Laboratories Private Limited?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Sainor Laboratories Private Limited?
See the directors and ownership sections above for board and shareholding detail. 7 active director(s) are on record.
Does Sainor Laboratories Private Limited have loans or charges against its assets?
11 open charge(s) are registered against its assets, and 9 earlier charge(s) stand satisfied.
Is Sainor Laboratories Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 66/100 (Moderate).
Is it risky to lend to Sainor Laboratories Private Limited?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
